Strides Pharma hits record high as arm gets USFDA nod for asthma drug

Strides Pharma Science advanced 2.12% to Rs 1,372.45 after its step-down wholly owned subsidiary, Strides Pharma Global Pte, Singapore, received US Food & Drug Administration (USFDA) approval for Theophylline Extended-Release tablets.